1. Metabolism and Pharmacological Mechanisms of Active Ingredients in Erigeron breviscapus
   Hua Fan et al, 2021, Current Drug Metabolism CrossRef
2. Scutellarin: Bioactivities, Pharmacology, and Development as Promising Therapeutic Agents and Nutraceuticals
   Natalie Vivien Gunter et al, 2023, Handbook of Dietary Flavonoids CrossRef
3. Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer’s Disease
   Xiaoyu Dong et al, 2022, Frontiers in Pharmacology CrossRef
4. Scutellarin Protects Myocardial Ischemia-Reperfusion Injury ERK1/2-CREB Regulated Mitophagy
   Wei-Wei Wang et al, 2023, Pharmacognosy Magazine CrossRef
5. Mitochondria Related Cell Death Modalities and Disease
   Chuwen Tian et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
6. Design, synthesis of amide derivatives of scutellarin and their antileukemia and neuroprotective activities
   Tong Han et al, 2022, Medicinal Chemistry Research CrossRef
7. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
   Rohit Pardeshi et al, 2019, Frontiers in Pharmacology CrossRef
8. Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
   Shanshan Nie et al, 2024, Frontiers in Pharmacology CrossRef